drugset / Trial / NCT01487200
Pharmacokinetic and Pharmacodynamic Study of FX006 in Patients With Osteoarthritis of the Knee
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study was to evaluate the safety, pharmacokinetics and pharmacodynamics of FX006 in patients with osteoarthritis of the knee.
Timeline
- Start
- 2012-07
- Primary completion
- 2012-11
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | TCA IR | Unknown | 40 mg | Other |
| Subject | Tafamidis | Unknown | 10 mg | Other |
| Subject | Tafamidis | Unknown | 40 mg | Other |
| Subject | Tafamidis | Unknown | 60 mg | Other |